Display options
Cite
Deer TR, Pope JE. Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process. Expert Rev Neurother. 2016;16(10):1123-5doi: 10.1080/14737175.2016.1206817.
Deer, T. R., & Pope, J. E. (2016). Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process. Expert review of neurotherapeutics, 16(10), 1123-5. https://doi.org/10.1080/14737175.2016.1206817
Deer, Timothy R, and Pope, Jason E. "Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process." Expert review of neurotherapeutics vol. 16,10 (2016): 1123-5. doi: https://doi.org/10.1080/14737175.2016.1206817
Deer TR, Pope JE. Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process. Expert Rev Neurother. 2016 Oct;16(10):1123-5. doi: 10.1080/14737175.2016.1206817. Epub 2016 Jul 25. PMID: 27454559.
Copy Download .nbib Format: NLM
Share it on

Expert Rev Neurother. 2016 Oct;16(10):1123-5. doi: 10.1080/14737175.2016.1206817. Epub 2016 Jul 25.

Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process.

Expert review of neurotherapeutics

Timothy R Deer, Jason E Pope

Affiliations

  1. a The Center for Pain Relief , Charleston , WV , USA.
  2. b Department of Anesthesiology , West Virginia University , Charleston , WV , USA.
  3. c Summit Pain Alliance , Santa Rosa , CA , USA.

PMID: 27454559 DOI: 10.1080/14737175.2016.1206817

[No abstract available.]

Keywords: Dorsal root ganglion stimulation; Food and Drug Administration; chronic pain; spinal cord stimulation

Publication Types